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advanced OA cartilage correlated significantly with BMI values
of the patients (r=0.610, p<0.05). SF had higher leptin con-
centrations than the paired serum sample, while a significant
correlation was observed between serum and SF leptin levels
(r=0.672, p<0.01). In normal chondrocytes cultures (48 hrs),
leptin enhanced cell proliferation but reduced it in osteoarthritic
chondrocytes, while in long term cultures leptin had a similar
detrimental effect on chondrocytes. Furthermore, leptin induced
the production of IL-1β in long term cultures.
Conclusions: For the first time to our knowledge, using quan-
titative real-time PCR, we observed leptin and Ob-Rb mRNA
expression in chondrocytes of osteoarthritic cartilage. The ob-
served intrajoint difference in leptin and Ob-Rb mRNA expres-
sion between advanced and minimally affected knee and hip
osteoarthritic cartilage, along with the higher observed leptin
concentrations in SF than in paired serum samples indicate a
local role of leptin in joint tissues. The increased leptin’s mRNA
expression in obese compared to normal weight patients sug-
gested that mechanical overload may alter chondrocytes’ phe-
notype. Also the decrease in chondrocyte’s proliferation after
induction with leptin points toward a long term detrimental ef-
fect on cartilage, while the observed IL-1β production suggests
an inflammatory role of leptin, which may account for cartilage
degradation. Taken together our findings support the hypothesis
that leptin is involved in OA development and that may be the
missing link between biomechanical and metabolic factors in-
volved in OA. However, further studies are needed to confirm the
involvement of leptin in OA and to investigate the link between
obesity, inflammation, leptin and osteoarthritis.
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Purpose: The matrix metalloproteinase (MMP) family consists
of 23 structurally related proteases that are able to degrade a
wide range of substrates, including many components of the ex-
tracellular matrix (ECM). MMP-28 (epilysin), is a recently cloned
member of the MMP family. We have recently described MMP28
expression in cartilage with significant increase in osteoarthri-
tis. The principle level of control of MMP expression is gene
transcription. The promoter region of both human and mouse
MMP28 has been cloned and characterised. Conserved mo-
tifs were identified that could control the expression of MMP28
including a GT-box situated 300 bp upstream from the trans-
lation start site that binds both Sp1 and Sp3 proteins and
is essential for MMP28 basal expression in keratinocytes. We
showed recently that histone deacetylase inhibitors (HDACi) are
chondroprotective. Whilst HDACi downregulate expression of a
number of MMPs, a small subset are induced and this includes
MMP28.
Methods: Promoter-reporter constructs were made in pGL3 and
transiently transfected into HeLa or SW1353 cells using Fu-
Gene6. DNA-protein interaction was assessed by gel mobility
shift assay. Acetylation of Sp1 and Sp3 was probed using im-
munoprecipitation with a specific antibody and Western blotting
with an anti-(pan acetyl lysine) antibody.
Results: Transient transfection assays with deletion constructs
of the MMP28 gene promoter, showed that HDACi, including
trichostatin A (TSA), valproic acid, sodium butyrate, upregulate
transcription from the promoter via the promoter proximal GT
described above. This was confirmed using point mutants in this
site. Gel mobility shift and supershift assays using Sp1/2/3 anti-
bodies showed that Sp1 and Sp3 bind to the MMP28 promoter
via the GT-box. Using transient transfection assays with the wild
type and mutant promoters we showed that Sp1, but not Sp3,
can induce the MMP28 promoter via the GT-box. HDACi induce
transcription from the promoter via Sp1 action at this site. Sp1 is
known to interact with the histone acetyltransferase (HAT) p300
and histone deacetylase 1 (HDAC1). Forced overexpression of
either p300 or PCAF, but not CBP (all of which are known HATs),
induces the MMP28 promoter, as does siRNA knockdown of
HDAC1. Sp1 and 3 can both be acetylated and phosphory-
lated which is reported to alter their DNA-binding properties.
In immunoprecipitation experiments, the acetylation of Sp1 and
Sp3 was increased by TSA treatment. Furthermore, the ser-
ine/threonine phosphatase inhibitor, okadaic acid can block the
TSA induction of the MMP28 promoter. Oligo pulldown experi-
ments have identified a 37kD protein which specifically interacts
with the GT-box, and this is currently being identified using mass
spectrometry.
Conclusions: These results suggest that acetylation regulates
the MMP28 gene via a promoter proximal GT-box which directly
binds and is activated by Sp1. Other proteins are also involved
in mediating the induction of MMP28, including at least p300,
PCAF, HDAC1 and a currently unidentified 37kD protein.
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Purpose: We recently identified RHOB as a gene over-
expressed in OA patients. The analysis of RHOB expression
revealed allelic imbalances indicating cis-regulatory mechanisms
and indeed, a single nucleotide polymorphism (SNP) at -165
in the RHOB promoter turned out to be associated with OA.
We here investigate in detail the regulation of RHOB expres-
sion and the functional consequences of its over-expression in a
chondrosarcoma line.
Methods: Apoptosis following over-expression of RHOB in the
human chondrosarcoma line SW1353 was assayed via quantifi-
cation of cells in the sub-G1 phase of the cell cycle and con-
firmed by confocal laser microscopy. Disease association of the
variable number of tandem repeats (VNTR) polymorphism was
determined by PCR. Luziferase assays in combination with re-
porter constructs were performed to measure the various RHOB
promoter activities.
Results: The RHOB genotyping data support a recessive model
for the SNP at -165 with the homozygous genotype (G/G) con-
ferring an Odds ratio of 4.3 to develop OA. An additional VNTR
polymorphism in the promoter region shows a distinct linkage
disequilibrium (LD) with the -165 SNP whereby in the controls
the T-allele is preferentially linked to 13 tandem repeats. In con-
trast, 10 tandem repeats are preferentially linked to the G-allele in
the patients. The corresponding p values indicating the linkages
are 0.0009 and 0.0144, respectively. The SubG1-assays reveal a
7-fold higher apoptosis rate of RHOB over-expressing cells com-
pared to cells expressing the normal endogenous levels. This
increase in cells entering the sub-G1 phase is paralleled by an
apoptotic phenotype of cell shrinking and flaking.
Conclusions: Our results support the concept of OA being
the consequence of active disease processes. We show that
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RHOB promoter polymorphisms cooperate in regulating RHOB
transcriptional activity and thus chondrocyte apoptosis whereby
an increase in chondrocyte apoptosis is predicted to result in the
net loss of articular cartilage.
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Purpose: Chondrogenic differentiation by mesenchymal stem
cells (MSCs) is associated with cytokines such as transforming
growth factor-β (TGF-β). This investigation was conducted to
examine the gene expression of the three isoforms of TGF-β
(1,2,3) and their receptors (TBR-I, TBR-II, TBR-III) in primary
MSCs culture established from bone marrow from patients with
end-stage osteoarthritis (OA).
Methods: MSCs were prepared from bone marrow aspirates
obtained from 18 patients undergoing joint replacement as a
result of OA and from 10 healthy donors. Total RNA was ex-
tracted from primary MSCs culture established from these cells
and quantitative real time reverse-transcription-polymerase chain
reaction was performed. Specific primers sequences of TGF-β
isoforms and their receptors, and rRNA18S, as internal control,
were used in this study. Shapiro-Wilk test was used to study the
normality of variables. Data are reported either as normalization
ratio (NR) mean ± SD in normal conditions or as NR median and
percentiles (percentile 25-percentile 75) if the variables did not fit
a Gaussian distribution. Normal variables were compared using
Student’s t test and non-normal variables using Mann-Whitney U
tests. P values less than 0.05 were considered significant.
Results: Compared to controls, total TGF-β mRNA expression
significantly increased in MSCs from OA patients. In relation to
TGF-β isoforms, only TGF-β1 showed a significant increase on
the expression in MSCs. TBR-I showed no significant change
between groups; however, both TBR-II and TBR-III increased
significantly in MSCs from OA patients compared with controls.
Data are summarized in table:
Gene expression of TGF-β, isoforms and receptors, in MSCs of OA patients
Gene NR OA patients NR controls p
TGF-β 0.61±0.28 0.40±0.24 0.042
TGF-β1 2.07±0.99 1.20±1.05 0.036
TGF-β2 2.25 [0.78-5.34] 2.94 [0.78-6.44] 0.982
TGF-β3 18.13 [11.20-27.29] 14.54 [0.35-25.5] 0.734
TBR-I 0.17 [0.05-0.76] 0.11 [0.06-0.31] 0.441
TBR-II 0.17 [0.08-0.26] 0.05 [0.02-0.06] 0.001
TBR-III 0.18 [0.07-1.38] 0.06 [0.03-0.35] 0.021
Conclusions: These results indicate that primary MSCs culture
established from patients with OA show an up-regulation on the
expression of total TGF-β, isoform TGF-β1, TBR-II and TBR-III
receptors. This response may be at the basis of inefficient wound
repair in cartilage in OA. Further studies should address the
possible involvement of the TGF-β1/TBRII and TBR-III system in
the pathophysiology of OA.
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Purpose: To confirm previous studies showing association of friz-
zled related protein 3 (FRZB) non-synonymous polymorphisms
with hip OA in women or with generalized OA, and to explore
possible involvement in other OA phenotypes.
Methods: A case-control study was done with three groups of
Spanish OA patients: patients that had undergone total joint
replacement for primary OA in the hip, THR (n = 310), or the
knee, TKR (n = 277) and patients with hand OA according to
the ACR classification criteria, HOA (n = 242). All patients were
specifically questioned and explored and their clinical records
were reviewed regarding the involvement of other joint regions.
Controls were more than 55 years old and were selected because
they did not show clinical OA symptoms (n = 294). SNPs resulting
in R200W (rs288326) and in R324G (rs7775) substitutions in
exons 4 and 6 of FRZB, respectively, were genotyped with
fluorogenic 5’ nuclease assays (TaqMan, AppliedBiosystems).
Results: There were not significant differences in allele frequen-
cies of any of the two SNPs between controls and each of the
three groups of OA patients. These results were not modified
by stratifying according to sex, or by pooling all OA patients in
a single group, or by considering genotypes at the two SNPs
jointly. However, allele G of the R324G SNP showed a trend
to higher frequency in patients with OA at multiple joints (p =
0.07). This trend was restricted to female patients (p = 0.10) and
more specifically to the subgroup of women in the THR group
(8.3% in patients without other affected joints versus 16.2% in
patients with them, p = 0.04). The increase in G allele frequency
was more marked in those patients showing a larger number of
OA affected joint regions (13.1% with one, 15.9% with two and
24.1% with more than two additionally affected joints, p = 0.006
for the trend).
Conclusions: These results add further evidence indicating that
the non-synonymous SNP in exon 6 of the FRZB gene play a role
in the development of OA. They suggest a subphenotype where
the effect could be clearer: female patients with polyarticular OA
and severe involvement of the hip joint. If this subphenotype
is confirmed with additional studies it will be compatible with
previous results that have found either association with hip OA
in females or with generalized OA in both sexes.
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Purpose: Osteoarthritic chondrocytes produce multiple cy-
clooxygenase and lipoxygenase products, predominantly
prostaglandin (PG) E2, which in turn affect chondrocyte phe-
notype. We report here the effects of PGE2 on the expres-
sion/activity of NURR1, an immediate early gene and member of
the nuclear receptor superfamily.
